Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia.

MLA

Ravandi, Farhad, et al. “Minimal Residual Disease Assessed by Multi-Parameter Flow Cytometry Is Highly Prognostic in Adult Patients with Acute Lymphoblastic Leukaemia.” British Journal of Haematology, vol. 172, no. 3, Feb. 2016, pp. 392–400. EBSCOhost, https://doi.org/10.1111/bjh.13834.

APA

Ravandi, F., Jorgensen, J. L., O’Brien, S. M., Jabbour, E., Thomas, D. A., Borthakur, G., Garris, R., Huang, X., Garcia, M. G., Burger, J. A., Ferrajoli, A., Wierda, W., Kadia, T., Jain, N., Wang, S. A., Konoplev, S., Kebriaei, P., Champlin, R. E., McCue, D., & Estrov, Z. (2016). Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia. British Journal of Haematology, 172(3), 392–400. https://doi.org/10.1111/bjh.13834

Chicago

Ravandi, Farhad, Jeffrey L. Jorgensen, Susan M. O’Brien, Elias Jabbour, Deborah A. Thomas, Gautam Borthakur, Rebecca Garris, et al. 2016. “Minimal Residual Disease Assessed by Multi-Parameter Flow Cytometry Is Highly Prognostic in Adult Patients with Acute Lymphoblastic Leukaemia.” British Journal of Haematology 172 (3): 392–400. doi:10.1111/bjh.13834.